Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04426539 · ClinicalTrials.gov registry record
New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study
A clinical trial, sponsored by American College of Radiology.
- Completed
- Registry status
- 6,061
- Enrollment target
NCT04426539 is a clinical trial that has completed, run by American College of Radiology. The registered enrollment target is 6,061 participants.
The verdict
NCT04426539 has completed, sponsored by American College of Radiology.
- COMPLETED
- Registry status
- 6,061 participants
- Enrollment target
Study Summary
New IDEAS is an observational, open-label, longitudinal cohort study designed to address the requirements of the CED provisions of the NCD on beta-amyloid PET. Building on the initial Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) study, New IDEAS will evaluate the association between amyloid PET and patient-centered outcomes in an expanded and more ethnoracially and clinically diverse group of Medicare participants presenting with cognitive impairment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,061 participants |
| Start Date | 2020-12-17 |
| Est. Completion | 2024-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04426539
The ClinicalTrials.gov registry entry for NCT04426539 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,061 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American College of Radiology, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04426539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04426539 about?
NCT04426539 is a clinical study titled "New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study". New IDEAS is an observational, open-label, longitudinal cohort study designed to address the requirements of the CED provisions of the NCD on beta-amyloid PET. Building on the initial Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) study, New IDEAS will evaluate the association between amyloi...
What is the current status of trial NCT04426539?
This trial is currently completed. The enrollment target is 6,061 participants. The study started on 2020-12-17. Estimated completion is 2024-12-31.
Who is sponsoring clinical trial NCT04426539?
This trial is sponsored by American College of Radiology, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.